Jefferies Group’s Aegerion Pharmaceuticals AEGR Stock Holding History

Jefferies Group’s Portfolio AEGR Stock Details AEGR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-461,300	Closed	-$4.66M	–	2807
2015 Q4	$4.66M	Buy	+461,300	New	+$5.55M	0.03%	503
2013 Q4	–	Sell	-500	Closed	-$43K	–	2375
2013 Q3	$43K	Buy	+500	New	+$42.4K	﹤0.01%	1783

Jefferies Group's AEGR Position: Q4 2016 in Review

Jefferies Group sold out of Aegerion Pharmaceuticals (AEGR) in Q4 2016, closing a stake of 712,948 shares — an estimated $2.12M sold.

Jefferies Group first reported a position in AEGR in Q3 2013 and held it in 7 quarters. The position peaked at $3.06M in Q2 2014. 0 funds tracked by Wall St. Rank hold AEGR as of Q4 2016.

Jefferies Group reported no remaining Aegerion Pharmaceuticals position as of Q4 2016 after selling out during the quarter.
Jefferies Group sold 712,948 Aegerion Pharmaceuticals shares in Q4 2016, an estimated $2.12M.
Jefferies Group first reported a position in Aegerion Pharmaceuticals in Q3 2013 and held it in 7 quarters.
Jefferies Group's Aegerion Pharmaceuticals position peaked at $3.06M in Q2 2014.
0 funds tracked by Wall St. Rank held Aegerion Pharmaceuticals as of Q4 2016.

Based on Jefferies Group's 13F filing for Q4 2016, filed 14 Feb 2017.